Transcriptional biomarkers

Methods

Volumn 59, Issue 1, 2013, Pages 1-2

  Pfaffl, Michael W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA;

CARDIOVASCULAR DISEASE; EDITORIAL; EPIGENETIC REPRESSION; EPIGENETICS; FAMILY HISTORY; GENE EXPRESSION PROFILING; GENOMICS; HEALTH STATUS; HIGH THROUGHPUT SCREENING; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULAR BIOLOGY; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA SEQUENCE; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA; TRANSCRIPTION, GENETIC;

EID: 84872196097     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2012.12.011     Document Type: Editorial

References (6)

1. Hulka B.S. Overview of biological markers. Biological Markers in Epidemiology 1990, 3-15. Oxford University Press, New York. B.S. Hulka, J.D. Griffith, T.C. Wilcosky (Eds.).
2. The Biomarkers Consortium is a public-private biomedical research partnership managed by the Foundation for the National Institutes of Health, http://www.biomarkersconsortium.org.
3. Atkinson A.J. Clin. Pharmacol. Ther. 2001, 69:89-95.
4. Sewall C.H., Bell D.A., Clark G.C., Tritscher A.M., Tully D.B., Vanden Heuvel J., Lucier G.W. Clin. Chem. 1995, 12(2):1829-1834.
5. Riedmaier I., Pfaffl M.W., Meyer H.H. Drug Test. Anal. 2012, 2012(Suppl. 1):70-74.
6. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. Rev. Clin. Chem. 2009, 55(4):611-622.